Zaid M Abdelsattar1,2, Samantha Hendren1,2, Sandra L Wong1,3. 1. Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan. 2. Department of Surgery, Mayo Clinic, Rochester, Minnesota. 3. Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
Abstract
BACKGROUND: Individuals from disadvantaged communities are among the millions of uninsured Americans gaining insurance under the Affordable Care Act. The extent to which health insurance can mitigate the effects of the social determinants of health on cancer care is unknown. METHODS: This study linked the Surveillance, Epidemiology, and End Results registries to US Census data to study patients diagnosed with the 4 leading causes of cancer deaths between 2007 and 2011. A county-level social determinant score was developed with 5 measures of wealth, education, and employment. Patients were stratified into quintiles, with the lowest quintile representing the most disadvantaged communities. Logistic regression and Cox proportional hazards models were used to estimate associations and cancer-specific survival. RESULTS: A total of 364,507 patients aged 18 to 64 years were identified (134,105 with breast cancer, 106,914 with prostate cancer, 62,606 with lung cancer, and 60,882 with colorectal cancer). Overall, patients from the most disadvantaged communities (median household income, $42,885; patients below the poverty level, 22%; patients completing college, 17%) were more likely to present with distant disease (odds ratio, 1.6; P < .001) and were less likely to receive cancer-directed surgery (odds ratio, 0.8; P < .001) than the least disadvantaged communities (median income, $78,249; patients below the poverty level, 9%; patients completing college, 42%). The differences persisted across quintiles regardless of the insurance status. The effect of having insurance on cancer-specific survival was more pronounced in disadvantaged communities (relative benefit at 3 years, 40% vs 31%). However, it did not fully mitigate the effect of social determinants on mortality (hazard ratio, 0.75 vs 0.68; P < .001). CONCLUSIONS: Cancer patients from disadvantaged communities benefit most from health insurance, and there is a reduction in disparities in outcome. However, the gap produced by social determinants of health cannot be bridged by insurance alone. Cancer 2017;123:1219-1227.
BACKGROUND: Individuals from disadvantaged communities are among the millions of uninsured Americans gaining insurance under the Affordable Care Act. The extent to which health insurance can mitigate the effects of the social determinants of health on cancer care is unknown. METHODS: This study linked the Surveillance, Epidemiology, and End Results registries to US Census data to study patients diagnosed with the 4 leading causes of cancer deaths between 2007 and 2011. A county-level social determinant score was developed with 5 measures of wealth, education, and employment. Patients were stratified into quintiles, with the lowest quintile representing the most disadvantaged communities. Logistic regression and Cox proportional hazards models were used to estimate associations and cancer-specific survival. RESULTS: A total of 364,507 patients aged 18 to 64 years were identified (134,105 with breast cancer, 106,914 with prostate cancer, 62,606 with lung cancer, and 60,882 with colorectal cancer). Overall, patients from the most disadvantaged communities (median household income, $42,885; patients below the poverty level, 22%; patients completing college, 17%) were more likely to present with distant disease (odds ratio, 1.6; P < .001) and were less likely to receive cancer-directed surgery (odds ratio, 0.8; P < .001) than the least disadvantaged communities (median income, $78,249; patients below the poverty level, 9%; patients completing college, 42%). The differences persisted across quintiles regardless of the insurance status. The effect of having insurance on cancer-specific survival was more pronounced in disadvantaged communities (relative benefit at 3 years, 40% vs 31%). However, it did not fully mitigate the effect of social determinants on mortality (hazard ratio, 0.75 vs 0.68; P < .001). CONCLUSIONS:Cancerpatients from disadvantaged communities benefit most from health insurance, and there is a reduction in disparities in outcome. However, the gap produced by social determinants of health cannot be bridged by insurance alone. Cancer 2017;123:1219-1227.
Authors: Michael T Halpern; Melissa A Romaire; Susan G Haber; Florence K Tangka; Susan A Sabatino; David H Howard Journal: Cancer Date: 2014-08-25 Impact factor: 6.860
Authors: Cheryl R Clark; Jane Soukup; Usha Govindarajulu; Heather E Riden; Dora A Tovar; Paula A Johnson Journal: Health Aff (Millwood) Date: 2011-02 Impact factor: 6.301
Authors: Blase N Polite; Jennifer J Griggs; Beverly Moy; Christopher Lathan; Nefertiti C duPont; Gina Villani; Sandra L Wong; Michael T Halpern Journal: J Clin Oncol Date: 2014-11-17 Impact factor: 44.544
Authors: S Yousuf Zafar; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy M Goetzinger; Xiaoyin Zhong; Amy P Abernethy Journal: Oncologist Date: 2013-02-26
Authors: Ibrahim Nassour; Hannah Fullington; Linda S Hynan; Adam C Yopp; Mathew M Augustine; Patricio M Polanco; Michael A Choti; John C Mansour; Sam C Wang; Matthew R Porembka Journal: Ann Surg Oncol Date: 2017-02-13 Impact factor: 5.344
Authors: Kristen E Rhodin; Cierra S Hong; Lindsey A Olivere; Elizabeth P Howell; Vinay K Giri; Kurren A Mehta; Taofik Oyekunle; Randall P Scheri; Betty C Tong; Julie A Sosa; Oluwadamilola M Fayanju Journal: J Surg Res Date: 2020-05-04 Impact factor: 2.192
Authors: Joshua P Kronenfeld; Emily L Ryon; David Goldberg; Rachel M Lee; Adam Yopp; Annie Wang; Ann Y Lee; Sommer Luu; Cary Hsu; Eric Silberfein; Maria C Russell; Alan S Livingstone; Nipun B Merchant; Neha Goel Journal: Ann Surg Oncol Date: 2020-09-25 Impact factor: 5.344
Authors: Sean T Massa; Nosayaba Osazuwa-Peters; Eric Adjei Boakye; Ronald J Walker; Gregory M Ward Journal: JAMA Otolaryngol Head Neck Surg Date: 2019-03-01 Impact factor: 6.223
Authors: Loretta Erhunmwunsee; Sam E Wing; Jenny Shen; Hengrui Hu; Ernesto Sosa; Lisa N Lopez; Catherine Raquel; Melissa Sur; Pilar Ibarra-Noriega; Madeline Currey; Janet Lee; Jae Y Kim; Dan J Raz; Arya Amini; Sagus Sampath; Marianna Koczywas; Erminia Massarelli; Howard L West; Karen L Reckamp; Rick A Kittles; Ravi Salgia; Victoria L Seewaldt; Susan L Neuhausen; Stacy W Gray Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-06-04 Impact factor: 4.254
Authors: Lindsey A Jones; Katherine C Brewer; Leslie R Carnahan; Jennifer A Parsons; Blase N Polite; Carol Estwing Ferrans; Richard B Warnecke; Garth H Rauscher Journal: Public Health Rep Date: 2021-03-31 Impact factor: 2.792